These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19246845)

  • 1. Admission levels of C-reactive protein and plasminogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission.
    Akkus MN; Polat G; Yurtdas M; Akcay B; Ercetin N; Cicek D; Doven O; Sucu N
    Int Heart J; 2009 Jan; 50(1):33-45. PubMed ID: 19246845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-hospital and long-term outcomes of cardiogenic shock complicating myocardial infarction versus heart failure.
    Choi KH; Kang D; Park H; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Gwon HC; Cho J; Yang JH
    Eur J Heart Fail; 2024 Jul; 26(7):1594-1603. PubMed ID: 38855925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein in acute myocardial infarction: association with heart failure.
    Berton G; Cordiano R; Palmieri R; Pianca S; Pagliara V; Palatini P
    Am Heart J; 2003 Jun; 145(6):1094-101. PubMed ID: 12796768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.
    Gjesdal G; Braun OÖ; Smith JG; Scherstén F; Tydén P
    BMC Cardiovasc Disord; 2018 Jan; 18(1):8. PubMed ID: 29347907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Urea Nitrogen to Left Ventricular Ejection Ratio as a Predictor of Short-Term Outcome in Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Xie L; Li Y; Chen J; Luo S; Huang B
    J Vasc Res; 2024; 61(5):233-243. PubMed ID: 39312885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected].
    Abdin A; Pöss J; Fuernau G; Ouarrak T; Desch S; Eitel I; de Waha S; Zeymer U; Böhm M; Thiele H
    Clin Res Cardiol; 2018 Jun; 107(6):517-523. PubMed ID: 29423774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.
    Collet JP; Montalescot G; Vicaut E; Ankri A; Walylo F; Lesty C; Choussat R; Beygui F; Borentain M; Vignolles N; Thomas D
    Circulation; 2003 Jul; 108(4):391-4. PubMed ID: 12860898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry.
    Wong SC; Sleeper LA; Monrad ES; Menegus MA; Palazzo A; Dzavik V; Jacobs A; Jiang X; Hochman JS;
    J Am Coll Cardiol; 2001 Nov; 38(5):1395-401. PubMed ID: 11691514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Obesity With In-Hospital Mortality of Cardiogenic Shock Complicating Acute Myocardial Infarction.
    Chatterjee K; Gupta T; Goyal A; Kolte D; Khera S; Shanbhag A; Patel K; Villablanca P; Agarwal N; Aronow WS; Menegus MA; Fonarow GC; Bhatt DL; Garcia MJ; Meena NK
    Am J Cardiol; 2017 May; 119(10):1548-1554. PubMed ID: 28363355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.
    Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP
    Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
    Singam NSV; Tabi M; Wiley B; Anavekar N; Jentzer J
    Int J Cardiol; 2023 Aug; 384():38-47. PubMed ID: 37116757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus.
    Lucci C; Cosentino N; Genovese S; Campodonico J; Milazzo V; De Metrio M; Rondinelli M; Riggio D; Biondi ML; Rubino M; Celentano K; Bonomi A; Capra N; Veglia F; Agostoni P; Bartorelli AL; Marenzi G
    Cardiovasc Diabetol; 2020 Oct; 19(1):183. PubMed ID: 33081810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The admission level of CRP during cardiogenic shock is a strong independent risk marker of mortality.
    Roubille F; Cherbi M; Kalmanovich E; Delbaere Q; Bonnefoy-Cudraz E; Puymirat E; Schurtz G; Gerbaud E; Bonello L; Lim P; Leurent G; Roubille C; Delmas C
    Sci Rep; 2024 Jul; 14(1):16338. PubMed ID: 39014136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction.
    Wada H; Ogita M; Suwa S; Nakao K; Ozaki Y; Kimura K; Ako J; Noguchi T; Yasuda S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Wake M; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
    Int Heart J; 2021 May; 62(3):520-527. PubMed ID: 33994511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock.
    Bae EH; Lim SY; Jeong MH; Park HW; Lim JH; Hong YJ; Kim W; Kim JH; Cho JG; Ahn YK; Park JC; Suh SP; Ahn BH; Kim SH; Kang JC
    Korean J Intern Med; 2005 Mar; 20(1):8-14. PubMed ID: 15906947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
    Wigger O; Bloechlinger S; Berger D; Häner J; Zanchin T; Windecker S; Räber L; Schefold JC
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):45-52. PubMed ID: 28838261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes.
    Sinha SS; Rosner CM; Tehrani BN; Maini A; Truesdell AG; Lee SB; Bagchi P; Cameron J; Damluji AA; Desai M; Desai SS; Epps KC; deFilippi C; Flanagan MC; Genovese L; Moukhachen H; Park JJ; Psotka MA; Raja A; Shah P; Sherwood MW; Singh R; Tang D; Young KD; Welch T; O'Connor CM; Batchelor WB
    Circ Heart Fail; 2022 Jun; 15(6):e009279. PubMed ID: 35510546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
    van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
    Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.